The Judgment Rule: Follow the Transition, Not the Award

For the SBIR program, the final question is not whether public funding matters. It is how far the evidence allows us to follow a specific technology from funded R&D into actual use. The judgment this series supports is therefore precise: an SBIR award establishes that a defined stage of research and development was selected and funded; it does not, by itself, establish that the technology was commercialized. To evaluate a stronger claim, identify the phase, follow the technology and its external relationships, name the outcome, check the time horizon, and preserve what the evidence cannot show.

The award establishes a stage, not an outcome

The program’s architecture makes the boundary clear. Phase I investigates feasibility and technical merit. Phase II continues R&D and may include prototyping. A sequential Phase II preserves development for a project that still needs more work. Phase III is the point at which commercialization is pursued through sources outside the ordinary SBIR Phase I and Phase II budgets. The progression matters because it moves a project toward a different set of decisions; it does not turn each earlier decision into a later result.

That is the answer to the title question. An award is not a commercial result because its immediate object is funded work, not completed market adoption. The award can create the conditions for commercialization: technical learning, a prototype, a team, a public mission connection, or a signal to other funders. But the later transition still requires an outside customer, investor, licensee, procurement office, production system, or other user to take a concrete step. The form of that step depends on the technology and its intended setting.

This distinction should not be confused with skepticism about SBIR. A public R&D program is allowed to finance work whose value is not yet visible in sales. The program’s purposes include stimulating technological innovation and meeting federal research and development needs, as well as increasing private-sector commercialization. A project serving a specialized public mission may create scientific or societal value without a large market. A project may generate expertise that supports a different product. Those are real possibilities, but they must be described as the outcomes they are. They cannot be used to claim commercial adoption without evidence of adoption.

The reverse is equally important. A technology should not be declared worthless because a sales record is missing. GAO found that commercialization data can be incomplete, self-reported, difficult to verify, or absent because firms are not required to report every outcome to every database. Some results occur after long development timelines. Some value is indirect or difficult to observe. The disciplined conclusion is not “no reported sale means no value.” It is “the available record does not establish a sale, so the claim must stop at the level the evidence supports.”

The difference between those two statements is the difference between evidence of absence and absence of evidence. Neither should be used as a shortcut. The first requires a sufficiently complete and relevant record showing that the expected outcome did not occur. The second describes an information boundary. SBIR commercialization claims are often made in precisely the space between those boundaries, where the award is highly visible but the later evidence is dispersed across technical reports, private financing, customer decisions, procurement records, and time.

A practical test for any commercialization claim

A reader can evaluate an SBIR claim through a sequence of questions. The questions are simple, but each prevents a different category error.

First, what phase was funded? A Phase I award supports a feasibility investigation. A Phase II award supports continued development or prototyping. A sequential Phase II is another continuation of R&D. A Phase III reference points to commercialization through a non-SBIR source, but it still needs to be tied to the specific event that occurred.